After hours:
Chart Events
Performance Outlook
| Previous Close | 70.03 |
| Open | 70.07 |
| Bid | 69.68 x 800 |
| Ask | 70.01 x 1100 |
| Day's Range | 69.59 - 70.45 |
| 52 Week Range | 64.62 - 104.83 |
| Volume | |
| Avg. Volume | 9,146,863 |
| Market Cap | 89.677B |
| Beta (5Y Monthly) | 0.61 |
| PE Ratio (TTM) | 31.88 |
| EPS (TTM) | 2.19 |
| Earnings Date | Oct 31, 2023 - Nov 06, 2023 |
| Forward Dividend & Yield | 2.42 (3.47%) |
| Ex-Dividend Date | Oct 19, 2023 |
| 1y Target Est | 90.54 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for CVS
Related Research
- CVS Health CorporationAnalyst Report: CVS Health CorporationCVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.RatingFair ValueEconomic Moat17 days agoMorningstar
PR NewswireAetna 2024 Medicare plans offer more choices, flexibility and simplicity
Aetna®, a CVS Health® company (NYSE: CVS), announces our 2024 Medicare products ― the largest Medicare offering in our history1 ― featuring more choices, flexible benefit allowances, a strong provider network and further simplified medical and prescription drug plans that support members' overall health and well-being. We included dental, vision and hearing benefits on every Medicare Advantage (MA) plan, reduced prescription drug costs across our Medicare Advantage Prescription Drug (MAPD) plan
Motley Fool2 Exceptional Dividend Stocks to Buy in October and Hold Forever
Investors looking for smart ways to bump up their stream of passive income want to push their shopping carts toward the healthcare aisle. Here's how they could pump up your recurring stream of passive income. Earlier this year, Johnson & Johnson spun its consumer health segment off into a new company called Kenvue.
Motley FoolHere's the Michael Burry Stock That Could Be the Biggest Winner Over the Next 5 Years
Burry has taken highly publicized short positions on Tesla stock. Here's the Michael Burry stock that could be the biggest winner over the next five years, in my opinion. You can easily find every stock that Burry's Scion Asset Management owns by looking at the private investment firm's 13-F filings to the U.S. Securities and Exchange Commission.
